Neuroethics Seminar: Innovation in Neurosurgery

Поділитися
Вставка
  • Опубліковано 10 тра 2016
  • Twitter: @HMSBioethics #neuroethx
    Be notified of the next event: bit.ly/1IswvA9
    About the series: bit.ly/1KEzG9s
    Facebook: / hmsbioethics
    -------------------------------------------------------
    If a neurosurgeon develops a new technique, when can it be considered innovation, and when should it be considered investigation? How novel must the technique be, before specific consent is required from the patient? When should regulatory authorities review the technique?
    We discuss these questions and more with two neurosurgeons experienced in innovation, bioethics, the law, and international regulation.
    ----- Speakers -----
    Joseph Madsen, MD
    Director, Epilepsy Surgery
    Children's Hospital Boston
    Marieke Broekman MD, PhD, JD
    Neurosurgery, University Medical Center Utrecht
    ----- About the Series -----
    The Neuroethics Seminar Series is designed to explore a diverse range of subjects at the intersection of neuroscience and ethics. In a typical seminar, three expert discussants will come together to explore a topic. In the 90-minute seminar, at least 30 minutes are reserved for discussion and audience participation.
    Learn more about the series and watch previous lectures:
    bioethics.hms.harvard.edu/neuroethics-seminar-series
    ----- Co-sponsors -----
    The International Neuroethics Society
    The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, HLS
    Center for Law, Brain, and Behavior, MGH
    Institute for the Neurosciences, BWH
    Center for Brain Science, Harvard University
    Department of Neurobiology, HMS
    ----- With funding from -----
    Mind Brain Behavior Interfaculty Initiative, Harvard University
    The Harvard Brain Initiative Collaborative Seed Grant Program
    Feel free to contact us at bioethics@hms.harvard.edu with any questions or comments about this event.

КОМЕНТАРІ •